Vor Biopharma Inc. Insider Trading Activity
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Insider Trade Summary
Grant/Award: 5,310,120 shares
Grant/Award
2 txns
Insider
Zuraw Qing Che
Role
Chief Development Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (right to buy) | 4,373,040 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 937,080 | $0.00 | $0.00 |
Holdings After Transaction:
Employee Stock Option (right to buy) — 4,373,040 options (Direct);
Common Stock — 937,080 shares (Direct)
Footnotes (2)
- F1. Represents the number of shares underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of common stock of the Issuer. 1/4th of the RSUs vest on August 1, 2026, with the remainder vesting in substantially equal quarterly installments over 3 years, in each case subject to the Reporting Person's continued service as of each such date.
- F2. 1/4th of the shares underlying the option vest on July 17, 2026, with the remainder vesting in substantially equal monthly installments over 3 years, in each case subject to the Reporting Person's continued service as of each such date.
AI-generated analysis. How Rhea-AI works. Not financial advice.